• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴基斯坦裔人群中的原发性高草酸尿症:文献回顾和两个主要登记处的结果。

Primary hyperoxaluria in populations of Pakistan origin: results from a literature review and two major registries.

机构信息

Department of Surgery (Urology), Aga Khan University, Stadium Road, P O Box 3500, Karachi, Pakistan.

Department of Nephrology, Birmingham Children's Hospital NHS Foundation Trust, Steelhouse Lane, Birmingham, B4 6 NH, UK.

出版信息

Urolithiasis. 2018 Apr;46(2):187-195. doi: 10.1007/s00240-017-0996-8. Epub 2017 Jun 28.

DOI:10.1007/s00240-017-0996-8
PMID:28660284
Abstract

Primary hyperoxalurias (PH) are devastating, autosomal recessive diseases causing renal stones. Undifferentiated hyperoxaluria is seen in up to 43% of Pakistani paediatric stone patients. High rates of consanguinity in Pakistan suggest significant local prevalence. There is no detailed information regarding number of cases, clinical features, and genetics in Pakistan-origin (P-o) patients. We reviewed available information on P-o PH patients recorded in the literature as well as from two major PH registries (the Rare Kidney Stone Consortium PH Registry (RKSCPHR) and the OxalEurope PH Registry (OxER); and the Aga Khan University Hospital in Pakistan. After excluding overlaps, we noted 217 P-o PH subjects (42 in OxER and 4 in RKSCPHR). Presentations were protean. Details of mutations were available for 94 patients of 201 who had genetic analyses. Unique mutations were noted. Mutation [c.508G>A (p. Gly170Arg)] (present in up to 25% in the West) was reported in only one case. In one series, only 30% had mutations on exons 1,4,7 of AGXT. Of 42 P-o patients in OxER, 52.4% were PH1, 45.2% PH2, and 2.4% PH3. Of concern is that diagnosis was made after renal transplant rejection (four cases) and on bone-marrow aspiration (in five). Lack of consideration of PH as a diagnosis, late diagnosis, and loss of transplanted kidneys mandates that PH be searched for diligently. Mutation analysis will need to extend to all exons and include PH 1,2,3. There is a need to spread awareness and identify patients through a scoring or screening system that alerts physicians to consider a diagnosis of PH.

摘要

原发性高草酸尿症 (PH) 是一种破坏性的常染色体隐性遗传病,可导致肾结石。在多达 43%的巴基斯坦儿科结石患者中可见未分化高草酸尿症。巴基斯坦近亲结婚率高,表明其局部患病率较高。目前尚无关于巴基斯坦裔(P-o)患者病例数量、临床特征和遗传学的详细信息。我们查阅了文献中记录的 P-o PH 患者以及两个主要 PH 登记处(罕见肾结石联盟 PH 登记处(RKSCPHR)和 OxalEurope PH 登记处(OxER)以及巴基斯坦 Aga Khan 大学医院的可用信息。排除重叠后,我们注意到 217 名 P-o PH 患者(42 名在 OxER,4 名在 RKSCPHR)。临床表现多样。对有基因分析的 201 名患者中的 94 名患者的突变细节进行了评估。注意到了独特的突变。突变 [c.508G>A (p. Gly170Arg)](在西方高达 25%的患者中存在)仅在一个病例中报道过。在一个系列中,只有 30%的患者在 AGXT 的外显子 1、4、7 上有突变。OxER 中的 42 名 P-o 患者中,52.4%为 PH1,45.2%为 PH2,2.4%为 PH3。值得关注的是,有 4 例是在肾移植排斥后,5 例是在骨髓抽吸后才做出 PH 的诊断。由于没有考虑将 PH 作为一种诊断,诊断较晚,以及移植肾脏丢失,因此需要积极寻找 PH。突变分析需要扩展到所有外显子,包括 PH1、2、3。需要通过评分或筛查系统来提高认识并识别患者,该系统可提醒医生考虑 PH 的诊断。

相似文献

1
Primary hyperoxaluria in populations of Pakistan origin: results from a literature review and two major registries.巴基斯坦裔人群中的原发性高草酸尿症:文献回顾和两个主要登记处的结果。
Urolithiasis. 2018 Apr;46(2):187-195. doi: 10.1007/s00240-017-0996-8. Epub 2017 Jun 28.
2
Mutational analysis of AGXT gene in Libyan children with primary hyperoxaluria type 1 at Tripoli Children Hospital.的黎波里儿童医院对1型原发性高草酸尿症利比亚儿童的AGXT基因进行突变分析。
Saudi J Kidney Dis Transpl. 2018 Jan-Feb;29(1):30-38. doi: 10.4103/1319-2442.225202.
3
Clinical spectrum of primary hyperoxaluria type 1: Experience of a tertiary center.1型原发性高草酸尿症的临床谱:一家三级中心的经验
Nephrol Ther. 2017 May;13(3):176-182. doi: 10.1016/j.nephro.2016.08.002. Epub 2017 Feb 1.
4
Updated genetic testing of Italian patients referred with a clinical diagnosis of primary hyperoxaluria.对临床诊断为原发性高草酸尿症的意大利患者进行的基因检测更新。
J Nephrol. 2017 Apr;30(2):219-225. doi: 10.1007/s40620-016-0287-4. Epub 2016 Mar 5.
5
Mutation spectrum of primary hyperoxaluria type 1 in Tunisia: implication for diagnosis in North Africa.突尼斯 1 型原发性高草酸尿症的突变谱:对北非诊断的影响。
Gene. 2013 Sep 15;527(1):316-20. doi: 10.1016/j.gene.2013.06.023. Epub 2013 Jun 25.
6
Molecular analysis of the AGXT gene in patients suspected with hyperoxaluria type 1 and three novel mutations from Turkey.对疑似1型高草酸尿症患者的AGXT基因进行分子分析及来自土耳其的三个新突变
Mol Genet Metab. 2016 Dec;119(4):311-316. doi: 10.1016/j.ymgme.2016.10.011. Epub 2016 Nov 1.
7
Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias.评估突变筛查作为原发性高草酸尿症诊断的一线检测方法。
Kidney Int. 2004 Sep;66(3):959-63. doi: 10.1111/j.1523-1755.2004.00842.x.
8
AGXT Gene Mutations and Prevalence of Primary Hyperoxaluria Type 1 in Moroccan Population.AGXT基因突变与摩洛哥人群中1型原发性高草酸尿症的患病率
Genet Test Mol Biomarkers. 2015 Nov;19(11):623-8. doi: 10.1089/gtmb.2015.0136. Epub 2015 Sep 18.
9
Identification of a novel AGXT gene mutation in primary hyperoxaluria after kidney transplantation failure.肾移植失败后原发性高草酸尿症中一种新型AGXT基因突变的鉴定。
Transpl Immunol. 2016 Nov;39:60-65. doi: 10.1016/j.trim.2016.08.008. Epub 2016 Aug 25.
10
Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria.原发性高草酸尿症的表型-基因型相关性及估计携带者频率
J Am Soc Nephrol. 2015 Oct;26(10):2559-70. doi: 10.1681/ASN.2014070698. Epub 2015 Feb 2.

引用本文的文献

1
Global access to management of primary hyperoxaluria: a survey on behalf of OxalEurope, G&K Working Group of the ERA and ESPN.全球原发性高草酸尿症管理的可及性:代表OxalEurope、欧洲罕见病研究协会G&K工作组和欧洲小儿肾脏病学会进行的一项调查
Nephrol Dial Transplant. 2025 Aug 29;40(9):1688-1697. doi: 10.1093/ndt/gfaf035.
2
Navigating the Evolving Landscape of Primary Hyperoxaluria: Traditional Management Defied by the Rise of Novel Molecular Drugs.原发性高草酸尿症的演变领域:新型分子药物的兴起对传统治疗方法提出挑战。
Biomolecules. 2024 Apr 23;14(5):511. doi: 10.3390/biom14050511.
3
Clinical features and mutational spectrum of Chinese patients with primary hyperoxaluria type 2.

本文引用的文献

1
An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.一种靶向乙醇酸氧化酶的研究性RNAi疗法可降低原发性高草酸尿症模型中的草酸盐生成。
J Am Soc Nephrol. 2017 Feb;28(2):494-503. doi: 10.1681/ASN.2016030338. Epub 2016 Jul 18.
2
Simultaneous analysis of urinary metabolites for preliminary identification of primary hyperoxaluria.同步分析尿液代谢物以初步鉴定原发性高草酸尿症。
Ann Clin Biochem. 2016 Jul;53(Pt 4):485-94. doi: 10.1177/0004563215606158. Epub 2015 Sep 4.
3
Primary hyperoxaluria type 1 diagnosed after kidney transplantation: The importance of pre-transplantation metabolic screening in recurrent urolithiasis.
中国 2 型原发性高草酸尿症患者的临床特征和突变谱。
Urolithiasis. 2024 May 10;52(1):74. doi: 10.1007/s00240-024-01579-y.
4
Clinical characteristics, genetic profile and short-term outcomes of children with primary hyperoxaluria type 2: a nationwide experience.原发性高草酸尿症 2 型患儿的临床特征、基因谱及短期预后:一项全国性经验。
Pediatr Nephrol. 2024 Apr;39(4):1093-1104. doi: 10.1007/s00467-023-06200-9. Epub 2023 Nov 2.
5
The real world experience of pediatric primary hyperoxaluria patients in the PEDSnet clinical research network.PEDSnet临床研究网络中儿科原发性高草酸尿症患者的真实世界经验。
Eur J Pediatr. 2023 Sep;182(9):4027-4036. doi: 10.1007/s00431-023-05077-y. Epub 2023 Jul 1.
6
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope.原发性高草酸尿症临床实践建议:来自欧洲罕见肾脏病网络(ERKNet)和欧洲草酸尿症协会(OxalEurope)的专家共识声明
Nat Rev Nephrol. 2023 Mar;19(3):194-211. doi: 10.1038/s41581-022-00661-1. Epub 2023 Jan 5.
7
A case report of invasive infantile primary hyperoxaluria type 1 and literature review.1 型婴儿侵袭性原发性高草酸尿症 1 例报告及文献复习。
CEN Case Rep. 2023 May;12(2):159-163. doi: 10.1007/s13730-022-00740-z. Epub 2022 Oct 4.
8
[Nephrolithiasis and nephrocalcinosis in children and adolescents].儿童和青少年的肾结石与肾钙质沉着症
Urologie. 2022 Oct;61(10):1099-1109. doi: 10.1007/s00120-022-01888-3. Epub 2022 Jul 8.
9
Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease.综合基因分析揭示单基因尿路结石病的复杂性。
Kidney Int Rep. 2021 Sep 8;6(11):2862-2884. doi: 10.1016/j.ekir.2021.08.033. eCollection 2021 Nov.
10
Determination of reference interval (RI) of spot urinary oxalate to creatinine ratio in children of pakistani origin under six years of age: A cross-sectional study.巴基斯坦裔6岁以下儿童随机尿草酸与肌酐比值参考区间的测定:一项横断面研究。
Ann Med Surg (Lond). 2021 Mar 30;64:102251. doi: 10.1016/j.amsu.2021.102251. eCollection 2021 Apr.
肾移植后诊断出的1型原发性高草酸尿症:复发性尿路结石中移植前代谢筛查的重要性。
Saudi J Kidney Dis Transpl. 2015 Jul-Aug;26(4):783-5. doi: 10.4103/1319-2442.160216.
4
Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria.原发性高草酸尿症的表型-基因型相关性及估计携带者频率
J Am Soc Nephrol. 2015 Oct;26(10):2559-70. doi: 10.1681/ASN.2014070698. Epub 2015 Feb 2.
5
Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria.肾钙质沉着症是原发性高草酸尿症导致肾衰竭的一个风险因素。
Kidney Int. 2015 Mar;87(3):623-31. doi: 10.1038/ki.2014.298. Epub 2014 Sep 17.
6
Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type.来自一项大型欧洲研究的数据表明,1 型原发性高草酸尿症的结局与 AGXT 突变类型相关。
Kidney Int. 2014 Dec;86(6):1197-204. doi: 10.1038/ki.2014.222. Epub 2014 Jul 2.
7
Ethnic differences in GRHPR mutations in patients with primary hyperoxaluria type 2.2 型原发性高草酸尿症患者中 GRHPR 突变的种族差异。
Clin Genet. 2014 Oct;86(4):342-8. doi: 10.1111/cge.12292. Epub 2013 Nov 5.
8
Common mutation underlying primary hyperoxaluria type1 in three Indian children.三名印度儿童原发性高草酸尿症1型的常见潜在突变
Indian J Nephrol. 2012 Nov;22(6):459-61. doi: 10.4103/0971-4065.106044.
9
Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies.原发性高草酸尿症 III 型患者的新发现及其对先进分子检测策略的影响。
Eur J Hum Genet. 2013 Feb;21(2):162-72. doi: 10.1038/ejhg.2012.139. Epub 2012 Jul 11.
10
Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.III 型原发性高草酸尿症基因 HOGA1(以前称为 DHDPSL)可能是特发性草酸钙尿石症的一个风险因素。
Clin J Am Soc Nephrol. 2011 Sep;6(9):2289-95. doi: 10.2215/CJN.02760311.